Literature DB >> 3290702

A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.

M Croxson1, P Brown, B Synek, M G Harrington, R Frith, G Clover, J Wilson, D C Gajdusek.   

Abstract

A clinically atypical, neuropathologically verified case of Creutzfeldt-Jakob disease is described in a 32-year-old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence (1970 to 1973) with human growth hormone processed from pooled cadaveric pituitary glands.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3290702     DOI： 10.1212/wnl.38.7.1128

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  3 in total

1.  Pituitary growth hormone and Creutzfeldt-Jakob disease.

Authors:  M E Macario; M Vaisman; A Buescu; V Moura Neto; H M Araujo; C Chagas
Journal:  BMJ       Date:  1991-05-11

Review 2.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.

Authors:  R J Cordery; M Hall; L Cipolotti; S Al-Sarraj; D G O'Donovan; L Davidson; P Adlard; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.